Drug Shortage Report for VINORELBINE INJECTION
Report ID | 33103 |
Drug Identification Number | 02265990 |
Brand name | VINORELBINE INJECTION |
Common or Proper name | Vinorelbine Injection, USP 10 mg/mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VINORELBINE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1mL SD Vial |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-14 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2017-12-31 |
Shortage status | Resolved |
Updated date | 2020-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-15 | English | Compare |
v2 | 2017-12-15 | French | Compare |
v3 | 2018-01-17 | English | Compare |
v4 | 2018-01-17 | French | Compare |
v5 | 2018-02-12 | English | Compare |
v6 | 2018-02-12 | French | Compare |
v7 | 2020-01-16 | English | Compare |
v8 | 2020-01-16 | French | Compare |
Showing 1 to 8 of 8